Avotermin Completed Phase 1 Trials for Promotion of wound healing / Cicatrix Prevention

Back to Avotermin
IndicationsStatusPurposePhase
CompletedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT00978302Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)